Comparison between endoscopic submucosal tunnel dissection and endoscopic submucosal dissection for superficial neoplasia at esophagogastric junction: a case-matched controlled study of a single center from China
- PMID: 35849242
- DOI: 10.1007/s00464-022-09289-5
Comparison between endoscopic submucosal tunnel dissection and endoscopic submucosal dissection for superficial neoplasia at esophagogastric junction: a case-matched controlled study of a single center from China
Abstract
Background: So far, little evidence is available for the comprehensive comparison of endoscopic submucosal tunnel dissection (ESTD) with endoscopic submucosal dissection (ESD) for the treatment of superficial neoplasia at esophagogastric junction (EGJ).
Methods: EGJ superficial neoplasia patients with ESTD treatment between January, 2021 and August, 2020 were retrospectively reviewed and individually matched at 1:1 ratio with those with ESD treatment according to lesion size, specimen area and lesion location, forming ESTD and ESD group, respectively. A sample size of 17 patients was collected for each group. Treatment outcomes including resection time, specimen area, and resection speed as well as occurrence of complications were evaluated.
Results: Compared with ESD group, ESTD group got shorter resection time (111.00 ± 11.70 min for ESD group vs. 71.59 ± 6.18 min for ESTD group, p = 0.008) and faster section speed (0.23 ± 0.03 cm2/min for ESD group vs. 0.37 ± 0.06 cm2/min for ESTD group, p = 0.012). No complication was found to occur in ESTD group, while 1 patient with MP damage and 1 with delayed bleeding was found in ESD group.
Conclusion: For the treatment of EGJ superficial neoplasia, ESTD is a safer and more effective and reliable endoscopic technique compared with ESD.
Keywords: Carcinoma; Endoscopic submucosal dissection; Endoscopic submucosal tunnel dissection; Esophagogastric junction; Superficial neoplasia.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Long-term outcomes of superficial neoplasia at the esophagogastric junction treated via endoscopic submucosal dissection and endoscopic submucosal tunnel dissection: a cohort study of a single center from China.Surg Endosc. 2020 Jan;34(1):216-225. doi: 10.1007/s00464-019-06753-7. Epub 2019 Apr 16. Surg Endosc. 2020. PMID: 30993514
-
Efficacy of endoscopic submucosal tunnel dissection versus endoscopic submucosal dissection for superficial esophageal neoplastic lesions: a systematic review and meta-analysis.Surg Endosc. 2021 Jan;35(1):52-62. doi: 10.1007/s00464-020-07925-6. Epub 2020 Aug 27. Surg Endosc. 2021. PMID: 32856152
-
Efficacy and safety of endoscopic submucosal tunnel dissection vs endoscopic submucosal dissection for early superficial upper gastrointestinal precancerous lesions and tumors: A meta-analysis.J Dig Dis. 2020 Sep;21(9):480-489. doi: 10.1111/1751-2980.12915. J Dig Dis. 2020. PMID: 32579253
-
Endoscopic submucosal tunnel dissection and endoscopic submucosal dissection for large superficial esophageal squamous cell neoplasm: efficacy and safety study to guide future practice.Surg Endosc. 2018 Jun;32(6):2814-2821. doi: 10.1007/s00464-017-5986-y. Epub 2017 Dec 20. Surg Endosc. 2018. PMID: 29264756
-
Endoscopic submucosal tunnel dissection for large superficial esophageal squamous cell neoplasms.World J Gastroenterol. 2016 Jan 7;22(1):435-45. doi: 10.3748/wjg.v22.i1.435. World J Gastroenterol. 2016. PMID: 26755889 Free PMC article. Review.
Cited by
-
Case Report: Endoscopic submucosal tunneling dissection using a golden knife for a giant gastric cancer lesion: a case report and literature review.Front Oncol. 2025 May 30;15:1450446. doi: 10.3389/fonc.2025.1450446. eCollection 2025. Front Oncol. 2025. PMID: 40519299 Free PMC article.
-
Two traction methods that can facilitate esophageal endoscopic submucosal dissection.World J Gastrointest Endosc. 2023 Apr 16;15(4):259-264. doi: 10.4253/wjge.v15.i4.259. World J Gastrointest Endosc. 2023. PMID: 37138940 Free PMC article. Review.
References
-
- Buas MF, Vaughan TL (2013) Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease. Sem Radiat Oncol 23(1):3–9 - DOI
-
- Munitiz V, Ortiz A, Ruiz de Angulo D, de Haro LFM, Parrilla P (2019) Results of the different surgical options for the treatment of cancer of the esophagogastric junction: Review of the evidence (Resultados de las diferentes opciones quirurgicas para el tratamiento del cancer de la union esofagogastrica. Revision de la evidencia). Cir Esp 97(8):445–50
-
- Zhang XD, Shu YQ, Liang J, Zhang FC, Ma XZ, Huang JJ, et al. (2012) Combination chemotherapy with paclitaxel, cisplatin and fluorouracil for patients with advanced and metastatic gastric or esophagogastric junction adenocarcinoma: a multicenter prospective study. Chin J Cancer Res Chung-kuo yen cheng yen chiu 24(4):291–298
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous